Optical coherence tomography angiography features of diabetic retinopathy

Retina

Volumn 35, Issue 11, 2015, Pages 2371-2376

  Hwang, Thomas S ^a   Jia, Yali ^a   Gao, Simon S ^a   Bailey, Steven T ^a   Lauer, Andreas K ^a   Flaxel, Christina J ^a   Wilson, David J ^a   Huang, David ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Diabetic retinopathy; En face OCT; OCT angiography

Indexed keywords

ADULT; ALGORITHM; ARTERIOLE; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; FOVEAL AVASCULAR ZONE; HUMAN; MALE; MICROANEURYSM; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PROLIFERATIVE DIABETIC RETINOPATHY; RETINA CAPILLARY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA NEOVASCULARIZATION; RETINAL CAPILLARY DROPOUT; VITREOUS BODY; ANEURYSM; BLOOD FLOW; BLOOD FLOW VELOCITY; CAPILLARY; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; RETINA BLOOD VESSEL; RETINAL NEOVASCULARIZATION; VASCULARIZATION;

ADULT; ANEURYSM; BLOOD FLOW VELOCITY; CAPILLARIES; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84946081900     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000716     Document Type: Article

References (16)

1. Antonetti D, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med 2012;366:1227-1239.
2. American Academy of Ophthalmology Retinal/Vitreous Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2014:1-65. Available at: www.aao.org/ppp. Accessed on October 11, 2014.
3. Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk factors for progression. Ophthalmology 1991;98(5 Suppl):834-840.
4. Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 1991;98(5 Suppl):807-822.
5. Bloome MA. Fluorescein angiography: risks. Vis Res 1980;20: 1083-1097.
6. University of Wisconsin Fundus Photograph Reading Center. Standard Fluorescein Angiography (FA-D). Madison, WI: University of Wisconsin School of Medicine and Public Health, 2012:1-10.
7. Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012;20:4710-4725.
8. Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 2014; 121:1435-1444.
9. Kim DY, Fingler J, Zawadzki RJ, et al. Noninvasive imaging of the foveal avascular zone with high-speed, phase-variance optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:85-92.
10. Schwartz DM, Fingler J, Kim DY, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology 2014;121:180-187.
11. Mansour AM, Schachat A, Bodiford G, Haymond R. Foveal avascular zone in diabetes mellitus. Retina 1993;13:125-128.
12. Wessel MM, Aaker GD, Parlitsis G, et al. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina 2012;32:785-791.
13. Kim DY, Kim J-G, Kim YJ, et al. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy. Invest Ophthalmol Vis Sci 2014;55:7040-7046.
14. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1449; 1449.e1-1449.e10.
15. Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology 1999;106:2068-2073.
16. Elman MJ, Aiello LP, Beck RWR, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.e35.